(MDGL) Madrigal - Performance 41.4% in 12m
Compare MDGL with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
69.42%
#6 in Group
Rel. Strength
88.70%
#905 in Universe
Total Return 12m
41.40%
#30 in Group
Total Return 5y
230.96%
#10 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -7.81%
(?) Percentile in Group
12m Total Return: MDGL (41.4%) vs XBI (-6.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: MDGL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MDGL
Total Return (including Dividends) | MDGL | XBI | S&P 500 |
---|---|---|---|
1 Month | -10.86% | -10.94% | -6.73% |
3 Months | -9.22% | -14.92% | -11.93% |
12 Months | 41.40% | -6.46% | 7.24% |
5 Years | 230.96% | -19.21% | 100.61% |
Trend Score (consistency of price movement) | MDGL | XBI | S&P 500 |
1 Month | -83.9% | -52.8% | -63.5% |
3 Months | -41.8% | -92.8% | -90.3% |
12 Months | 72.1% | -32.4% | 60.6% |
5 Years | 65.9% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #102 | 0.10% | -4.42% |
3 Month | #58 | 6.71% | 3.08% |
12 Month | #31 | 51.2% | 31.9% |
5 Years | #10 | 310% | 65.0% |
FAQs
Does MDGL Madrigal outperforms the market?
Yes,
over the last 12 months MDGL made 41.40%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months MDGL made -9.22%, while XBI made -14.92%.
Over the last 3 months MDGL made -9.22%, while XBI made -14.92%.
Performance Comparison MDGL vs Indeces and Sectors
MDGL vs. Indices MDGL is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -1.53% | -4.13% | 59.3% | 34.2% |
US NASDAQ 100 | QQQ | -2.01% | -3.50% | 59.1% | 33.8% |
US Dow Jones Industrial 30 | DIA | 0.50% | -3.95% | 58.7% | 36.9% |
German DAX 40 | DAX | -2.75% | -6.92% | 39.4% | 21.1% |
Shanghai Shenzhen CSI 300 | CSI 300 | -0.96% | -7.47% | 58.1% | 32.2% |
Hongkong Hang Seng | HSI | -4.20% | -7.14% | 54.7% | 24.6% |
India NIFTY 50 | INDA | -3.68% | -12.9% | 55.9% | 38.4% |
Brasil Bovespa | EWZ | -5.80% | -11.3% | 54.2% | 50.1% |
MDGL vs. Sectors MDGL is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -2.24% | -4.01% | 50.1% | 26.3% |
Consumer Discretionary | XLY | -2.97% | -4.02% | 54.0% | 30.1% |
Consumer Staples | XLP | -1.68% | -13.8% | 51.3% | 30.1% |
Energy | XLE | -1.60% | 1.64% | 60.6% | 54.1% |
Financial | XLF | -2.23% | -6.01% | 50.4% | 23.6% |
Health Care | XLV | 0.74% | -3.10% | 61.5% | 43.8% |
Industrial | XLI | -0.93% | -4.83% | 59.4% | 37.3% |
Materials | XLB | -1.27% | -5.01% | 66.5% | 47.3% |
Real Estate | XLRE | -1.30% | -7.63% | 59.6% | 26.7% |
Technology | XLK | -1.80% | -1.86% | 65.5% | 40.2% |
Utilities | XLU | -1.42% | -11.1% | 55.6% | 19.7% |
Aerospace & Defense | XAR | -0.08% | -7.68% | 49.9% | 19.5% |
Biotech | XBI | -4.95% | 0.08% | 70.7% | 47.9% |
Homebuilder | XHB | -3.06% | -2.74% | 74.0% | 51.9% |
Retail | XRT | -3.40% | -5.47% | 62.7% | 47.7% |